A discussion regarding the legal protections for vaccine manufacturers highlights the lack of liability for adverse reactions as a primary driver of industry profits. Historical examples, including the 1976 swine flu vaccine and the 2006 HPV vaccine rollout, are cited as instances where public health initiatives were allegedly prioritized over safety concerns. Critics argue that removing liability shields would force higher standards in vaccine processing.




